Can cancer trigger autoimmunity?

Science

Volumn 343, Issue 6167, 2014, Pages 147-148

  Teng, Michele W L ^a,b   Smyth, Mark J ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CENTROMERE PROTEIN B; DNA DIRECTED RNA POLYMERASE III; DNA TOPOISOMERASE; TUMOR ANTIGEN; AUTOANTIGEN; POLYMERASE III POLYPEPTIDE A, HUMAN;

CANCER; DEVELOPMENTAL BIOLOGY; DISEASE PREVALENCE; DISEASE TREATMENT; IMMUNE RESPONSE; IMMUNITY; NUMERICAL MODEL;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CARCINOGENESIS; DISEASE FREE SURVIVAL; GENE; GENE DOSAGE; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; NEOPLASM; NONHUMAN; PARANEOPLASTIC SYNDROME; POLYMERASE III POLYPEPTIDE A GENE; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; TUMOR IMMUNITY; WILD TYPE; IMMUNOLOGY; NOTE;

AUTOANTIGENS; AUTOIMMUNE DISEASES; HUMANS; NEOPLASMS; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC;

EID: 84892168459     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1249486     Document Type: Review

References (8)

1. C. G. Joseph et al., Science 343, 152 (2014); 10.1126/ science.1246886.
2. A. A. Shah, A. Rosen, L. Hummers, F. Wigley, L. CasciolaRosen, Arthritis Rheum. 62, 2787 (2010).
3. R. D. Schreiber, L. J. Old, M. J. Smyth, Science 331, 1565 (2011).
4. H. Matsushita et al., Nature 482, 400 (2012).
5. J. Galon et al., Science 313, 1960 (2006).
6. A. Ablasser et al., Nat. Immunol. 10, 1065 (2009).
7. J. E. Naschitz, Curr. Opin. Rheumatol. 13, 62 (2001).
8. M. L. Albert, R. B. Darnell, Nat. Rev. Cancer 4, 36 (2004)